|
1
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer, and cancer stem cells. Nature.
414:105–111. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sánchez Alvarado A and Yamanaka S:
Rethinking differentiation: Stem cells, regeneration, and
plasticity. Cell. 157:110–119. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sottoriva A, Verhoeff JJ, Borovski T,
McWeeney SK, Naumov L, Medema JP, Sloot PM and Vermeulen L: Cancer
stem cell tumor model reveals invasive morphology and increased
phenotypical heterogeneity. Cancer Res. 70:46–56. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yu Y, Ramena G and Elble RC: The role of
cancer stem cells in relapse of solid tumors. Front Biosci (Elite
Ed). 4:1528–1541. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zeuner A, Todaro M, Stassi G and De Maria
R: Colorectal cancer stem cells: From the crypt to the clinic. Cell
Stem Cell. 15:692–705. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pattabiraman DR and Weinberg RA: Tackling
the cancer stem cells-what challenges do they pose? Nat Rev Drug
Discov. 13:497–512. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Choi SA, Lee JY, Phi JH, Wang KC, Park CK,
Park SH and Kim SK: Identification of brain tumour initiating cells
using the stem cell marker aldehyde dehydrogenase. Eur J Cancer.
50:137–149. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
O'Brien CA, Pollett A, Gallinger S and
Dick JE: A human colon cancer cell capable of initiating tumour
growth in immunodeficient mice. Nature. 445:106–110. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Collins AT, Berry PA, Hyde C, Stower MJ
and Maitland NJ: Prospective identification of tumorigenic prostate
cancer stem cells. Cancer Res. 65:10946–10951. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bao B, Ahmad A, Azmi AS, Ali S and Sarkar
FH: Overview of cancer stem cells (CSCs) and mechanisms of their
regulation: Implications for cancer therapy. Curr Protoc Pharmacol.
Chapter 14: Unit 14.25. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bussolati B, Bruno S, Grange C,
Buttiglieri S, Deregibus MC, Cantino D and Camussi G: Isolation of
renal progenitor cells from adult human kidney. Am J Pathol.
166:545–555. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kim CF, Jackson EL, Woolfenden AE,
Lawrence S, Babar I, Vogel S, Crowley D, Bronson RT and Jacks T:
Identification of bronchioalveolar stem cells in normal lung and
lung cancer. Cell. 121:823–835. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fang D, Nguyen TK, Leishear K, Finko R,
Kulp AN, Hotz S, Van Belle PA, Xu X, Elder DE and Herlyn M: A
tumorigenic subpopulation with stem cell properties in melanomas.
Cancer Res. 65:9328–9337. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hoshi N, Kusakabe T, Taylor BJ and Kimura
S: Side population cells in the mouse thyroid exhibit
stem/progenitor cell-like characteristics. Endocrinology.
148:4251–4258. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kato K, Takao T, Kuboyama A, Tanaka Y,
Ohgami T, Yamaguchi S, Adachi S, Yoneda T, Ueoka Y, Kato K, et al:
Endometrial cancer side-population cells show prominent migration
and have a potential to differentiate into the mesenchymal cell
lineage. Am J Pathol. 176:381–392. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lapidot T, Sirard C, Vormoor J, Murdoch B,
Hoang T, Caceres-Cortes J, Minden M, Paterson B, Caligiuri MA and
Dick JE: A cell initiating human acute myeloid leukaemia after
transplantation into SCID mice. Nature. 367:645–648. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ginestier C, Hur MH, Charafe-Jauffret E,
Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG,
Liu S, et al: ALDH1 is a marker of normal and malignant human
mammary stem cells and a predictor of poor clinical outcome. Cell
Stem Cell. 1:555–567. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Singh SK, Hawkins C, Clarke ID, Squire JA,
Bayani J, Hide T, Henkelman RM, Cusimano MD and Dirks PB:
Identification of human brain tumour initiating cells. Nature.
432:396–401. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Suetsugu A, Nagaki M, Aoki H, Motohashi T,
Kunisada T and Moriwaki H: Characterization of CD133+
hepatocellular carcinoma cells as cancer stem/progenitor cells.
Biochem Biophys Res Commun. 351:820–824. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li C, Heidt DG, Dalerba P, Burant CF,
Zhang L, Adsay V, Wicha M, Clarke MF and Simeone DM: Identification
of pancreatic cancer stem cells. Cancer Res. 67:1030–1037. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Su J, Xu XH, Huang Q, Lu MQ, Li DJ, Xue F,
Yi F, Ren JH and Wu YP: Identification of cancer stem-like
CD44+ cells in human nasopharyngeal carcinoma cell line.
Arch Med Res. 42:15–21. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Prince ME, Sivanandan R, Kaczorowski A,
Wolf GT, Kaplan MJ, Dalerba P, Weissman IL, Clarke MF and Ailles
LE: Identification of a subpopulation of cells with cancer stem
cell properties in head and neck squamous cell carcinoma. Proc Natl
Acad Sci USA. 104:973–978. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhou L, Wei X, Cheng L, Tian J and Jiang
JJ: CD133, one of the markers of cancer stem cells in Hep-2 cell
line. Laryngoscope. 117:455–460. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shi C, Tian R, Wang M, Wang X, Jiang J,
Zhang Z, Li X, He Z, Gong W and Qin R: CD44+
CD133+ population exhibits cancer stem cell-like
characteristics in human gallbladder carcinoma. Cancer Biol Ther.
10:1182–1190. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Landen CN Jr, Goodman B, Katre AA, Steg
AD, Nick AM, Stone RL, Miller LD, Mejia PV, Jennings NB, Gershenson
DM, et al: Targeting aldehyde dehydrogenase cancer stem cells in
ovarian cancer. Mol Cancer Ther. 9:3186–3199. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cui F, Wang J, Chen D and Chen YJ: CD133
is a temporary marker of cancer stem cells in small cell lung
cancer, but not in non-small cell lung cancer. Oncol Rep.
25:701–708. 2011.PubMed/NCBI
|
|
28
|
Liang D and Shi Y: Aldehyde
dehydrogenase-1 is a specific marker for stem cells in human lung
adenocarcinoma. Med Oncol. 29:633–639. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Prud'homme GJ: Cancer stem cells and novel
targets for antitumor strategies. Curr Pharm Des. 18:2838–2849.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Pang R, Law WL, Chu AC, Poon JT, Lam CS,
Chow AK, Ng L, Cheung LW, Lan XR, Lan HY, et al: A subpopulation of
CD26+ cancer stem cells with metastatic capacity in
human colorectal cancer. Cell Stem Cell. 6:603–615. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Miraglia S, Godfrey W, Yin AH, Atkins K,
Warnke R, Holden JT, Bray RA, Waller EK and Buck DW: A novel
five-transmembrane hematopoietic stem cell antigen: Isolation,
characterization, and molecular cloning. Blood. 90:5013–5021.
1997.PubMed/NCBI
|
|
32
|
Ricci-Vitiani L, Lombardi DG, Pilozzi E,
Biffoni M, Todaro M, Peschle C and De Maria R: Identification and
expansion of human colon-cancer-initiating cells. Nature.
445:111–115. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Pardal R, Clarke MF and Morrison SJ:
Applying the principles of stem-cell biology to cancer. Nat Rev
Cancer. 3:895–902. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Dong HJ, Jang GB, Lee HY, Park SR, Kim JY,
Nam JS and Hong IS: The Wnt/β-catenin signaling/Id2 cascade
mediates the effects of hypoxia on the hierarchy of
colorectal-cancer stem cells. Sci Rep. 6:229662016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Turner PV, Pekow C, Clark JM, Vergara P,
Bayne K, White WJ, Kurosawa TM, Seok SH and Baneux P: Roles of the
international council for laboratory animal science (ICLAS) and
international association of colleges of laboratory animal medicine
(IACLAM) in the global organization and support of 3Rs advances in
laboratory animal science. J Am Assoc Lab Anim Sci. 54:174–180.
2015.PubMed/NCBI
|
|
36
|
Edge SB, Byrd DR, Compton CC, Fritz AG,
Greene FL and Trotti A: AJCC Cancer Staging Manual. 7th. Springer;
New York, NY: 2010
|
|
37
|
Kojima M, Ishii G, Atsumi N, Fujii S,
Saito N and Ochiai A: Immunohistochemical detection of CD133
expression in colorectal cancer: A clinicopathological study.
Cancer Sci. 99:1578–1583. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Fromowitz FB, Viola MV, Chao S, Oravez S,
Mishriki Y, Finkel G, Grimson R and Lundy J: ras p21 expression in
the progression of breast cancer. Hum Pathol. 18:1268–1275. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Louis KS and Siegel AC: Cell viability
analysis using trypan blue: Manual and automated methods. Methods
Mol Biol. 740:7–12. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Guo Y, Guo H, Zhang L, Xie H, Zhao X, Wang
F, Li Z, Wang Y, Ma S, Tao J, et al: Genomic analysis of
anti-hepatitis B virus (HBV) activity by small interfering RNA and
lamivudine in stable HBV-producing cells. J Virol. 79:14392–14403.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Phillips J and Eberwine JH: Antisense RNA
amplification: A linear amplification method for analyzing the mRNA
population from single living cells. Methods. 10:283–288. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
MAQC Consortium, ; Shi L, Reid LH, Jones
WD, Shippy R, Warrington JA, Baker SC, Collins PJ, de Longueville
F, Kawasaki ES, et al: The MicroArray Quality Control (MAQC)
project shows inter- and intraplatform reproducibility of gene
expression measurements. Nat Biotechnol. 24:1151–1161. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Patterson TA, Lobenhofer EK,
Fulmer-Smentek SB, Collins PJ, Chu TM, Bao W, Fang H, Kawasaki ES,
Hager J, Tikhonova IR, et al: Performance comparison of one-color
and two-color platforms within the MicroArray Quality Control
(MAQC) project. Nat Biotechnol. 24:1140–1150. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Horst D, Kriegl L, Engel J, Kirchner T and
Jung A: CD133 expression is an independent prognostic marker for
low survival in colorectal cancer. Br J Cancer. 99:1285–1289. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Mărgaritescu C, Pirici D, Cherciu I,
Bărbălan A, Cârtână T and Săftoiu A: CD133/CD166/Ki-67 triple
immunofluorescence assessment for putative cancer stem cells in
colon carcinoma. J Gastrointestin Liver Dis. 23:161–170. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Lugli A, Iezzi G, Hostettler I, Muraro MG,
Mele V, Tornillo L, Carafa V, Spagnoli G, Terracciano L and Zlobec
I: Prognostic impact of the expression of putative cancer stem cell
markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer.
Br J Cancer. 103:382–390. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Tu Y, Gao X, Li G, Fu H, Cui D, Liu H, Jin
W and Zhang Y: MicroRNA-218 inhibits glioma invasion, migration,
proliferation, and cancer stem-like cell self-renewal by targeting
the polycomb group gene Bmi1. Cancer Res. 73:6046–6055. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Liu S, Dontu G, Mantle ID, Patel S, Ahn
NS, Jackson KW, Suri P and Wicha MS: Hedgehog signaling and Bmi-1
regulate self-renewal of normal and malignant human mammary stem
cells. Cancer Res. 66:6063–6071. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
de Jonge-Peeters SD, Kuipers F, de Vries
EG and Vellenga E: ABC transporter expression in hematopoietic stem
cells and the role in AML drug resistance. Crit Rev Oncol Hematol.
62:214–226. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Blaj C, Schmidt EM, Lamprecht S, Hermeking
H, Jung A, Kirchner T and Horst D: Oncogenic effects of High MAPK
activity in colorectal cancer mark progenitor cells and persist
irrespective of RAS mutations. Cancer Res. 77:1763–1774. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Fang JY and Richardson BC: The MAPK
signalling pathways and colorectal cancer. Lancet Oncol. 6:322–327.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Sunayama J, Matsuda K, Sato A, Tachibana
K, Suzuki K, Narita Y, Shibui S, Sakurada K, Kayama T, Tomiyama A
and Kitanaka C: Crosstalk between the PI3K/mTOR and MEK/ERK
pathways involved in the maintenance of self-renewal and
tumorigenicity of glioblastoma stem-like cells. Stem Cells.
28:1930–1939. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Belle JI, Petrov JC, Langlais D, Robert F,
Cencic R, Shen S, Pelletier J, Gros P and Nijnik A: Repression of
p53-target gene Bbc3/PUMA by MYSM1 is essential for the survival of
hematopoietic multipotent progenitors and contributes to stem cell
maintenance. Cell Death Differ. 23:759–775. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Vogelstein B, Lane D and Levine AJ:
Surfing the p53 network. Nature. 408:307–310. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Li XL, Zhou J, Chen ZR and Chng WJ: P53
mutations in colorectal cancer-molecular pathogenesis and
pharmacological reactivation. World J Gastroenterol. 21:84–93.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Vogelstein B and Kinzler KW: Cancer genes
and the pathways they control. Nat Med. 10:789–799. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Fuchs B, O'Connor D, Fallis L, Scheidtmann
KH and Lu X: p53 phosphorylation mutants retain transcription
activity. Oncogene. 10:789–793. 1995.PubMed/NCBI
|
|
59
|
Melnikova VO, Santamaria AB, Bolshakov SV
and Ananthaswamy HN: Mutant p53 is constitutively phosphorylated at
Serine 15 in UV-induced mouse skin tumors: Involvement of ERK1/2
MAP kinase. Oncogene. 22:5958–5966. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Cordenonsi M, Montagner M, Adorno M,
Zacchigna L, Martello G, Mamidi A, Soligo S, Dupont S and Piccolo
S: Integration of TGF-beta and Ras/MAPK signaling through p53
phosphorylation. Science. 315:840–843. 2007. View Article : Google Scholar : PubMed/NCBI
|
